Is a positive nasal lysine-aspirin challenge test associated with a more severe phenotype of chronic rhinosinusitis and asthma?

American Journal of Rhinology and Allergy

Volumn 26, Issue 3, 2012, Pages

  Vaidyanathan, Sriram ^a   Williamson, Peter A ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LYSINE; METHACHOLINE;

ACOUSTIC RHINOMETRY; ADULT; AGED; ARTICLE; ASTHMA; CHRONIC RHINOSINUSITIS; CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; DRUG HYPERSENSITIVITY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; NASAL LYSINE ASPIRIN CHALLENGE TEST; NOSE AIRWAY RESISTANCE; NOSE POLYP; NOSE PROVOCATION TEST; PEAK NASAL INSPIRATORY FLOW; PHENOTYPE; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SMELLING; SPIROMETRY;

ADULT; AGED; ASPIRIN; ASTHMA, ASPIRIN-INDUCED; CHRONIC DISEASE; FEMALE; HUMANS; LYSINE; MALE; MIDDLE AGED; NASAL PROVOCATION TESTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RHINITIS; RHINOMETRY, ACOUSTIC; SENSITIVITY AND SPECIFICITY; SINUSITIS;

EID: 84862156624     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2012.26.3767     Document Type: Article

References (36)

1. Bachert C, Van Bruaene N, Toskala E, et al. Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis-A GA2LEN study. Allergy 64:520-533, 2009.
2. Berges-Gimeno MP, Simon RA, and Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 89:474-478, 2002. (Pubitemid 36187990)
3. Jenneck C, Juergens U, Buecheler M, et al. Pathogenesis, diagnosis, and treatment of aspirin intolerance. Ann Allergy Asthma Immunol 99:13-21, 2007. (Pubitemid 47075945)
4. Widal F, Abrami P, and Lermoyez J. First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome (plus urticaria)-1922 (with a note on aspirin desensitization). J Asthma 24:297-300, 1987.
5. Lin DC, Chandra RK, Tan BK, et al. Association between severity of asthma and degree of chronic rhinosinusitis. Am J Rhinol Allergy 25:205-208, 2011.
6. Mascia K, Haselkorn T, Deniz YM, et al. Aspirin sensitivity and severity of asthma: Evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol 116:970-975, 2005. (Pubitemid 41571774)
7. Fokkens W, Lund V, and Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 45:1-136, 2007.
8. Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 38:260-275, 2008.
9. Szczeklik A, and Nizankowska E. Clinical features and diagnosis of aspirin induced asthma. Thorax 55 Suppl 2:S42-S44, 2000.
10. Katotomichelakis M, Riga M, Davris S, et al. Allergic rhinitis and aspirin-exacerbated respiratory disease as predictors of the olfactory outcome after endoscopic sinus surgery. Am J Rhinol Allergy 23:348-353, 2009.
11. Fokkens W, Lund V, and Mullol J. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 45:97-101, 2007.
12. Jenkins C, Costello J, and Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 328:434, 2004.
13. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, et al. EAACI/GA2LEN guideline: Aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 62:1111-1118, 2007. (Pubitemid 47374015)
14. Killen JW, Wilson JA, and Gibson GJ. Subclinical aspirin sensitivity in subjects with nasal polyposis. Clin Otolaryngol Allied Sci 28:539-544, 2003. (Pubitemid 37491666)
15. Lildholdt T, Rundcrantz H, and Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: A double-blind, placebo-controlled study of budesonide. Clin Otolaryngol Allied Sci 20:26-30, 1995.
16. Casadevall J, Ventura PJ, Mullol J, et al. Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: Evaluation of nasal response by acoustic rhinometry. Thorax 55:921-924, 2000.
17. Lee DK, Haggart K, and Lipworth BJ. Reproducibility of response to nasal lysine-aspirin challenge in patients with aspirin-induced asthma. Ann Allergy Asthma Immunol 93:185-188, 2004. (Pubitemid 39128500)
18. Gonzalez-Perez R, Poza-Guedes P, and Vives-Conesa R. The nose as a target organ in the diagnosis of severe aspirin-exacerbated respiratory disease. Am J Rhinol Allergy 25:166-169, 2011.
19. Johansson L, Holmberg K, Melen I, et al. Sensitivity of a new grading system for studying nasal polyps with the potential to detect early changes in polyp size after treatment with a topical corticosteroid (budesonide). Acta Otolaryngol 122:49-53, 2002. (Pubitemid 34171360)
20. Barnes ML, Vaidyanathan S, Williamson PA, et al. The minimal clinically important difference in allergic rhinitis. Clin Exp Allergy 40:242-250, 2010.
21. Sims EJ, Wilson AM, White PS, et al. Short term repeatability and correlates of laboratory measures of nasal function in patients with seasonal allergic rhinitis. Rhinology 40:66-68, 2002. (Pubitemid 34624902)
22. Barnes ML, Ward JH, Fardon TC, et al. Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis. Clin Exp Allergy 36:676-684, 2006.
23. Mackay IS, and Durham SR. ABC of allergies. Perennial rhinitis. BMJ 316:917-920, 1998. (Pubitemid 28120872)
24. Juniper EF, Thompson AK, Ferrie PJ, et al. Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 30:132-140, 2000. (Pubitemid 30093890)
25. American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171:912-930, 2005.
26. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 26:319-338, 2005. (Pubitemid 41079078)
27. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 26:511-522, 2005. (Pubitemid 41264217)
28. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 161:309-329, 2000.
29. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. J Allergy Clin Immunol 114:155-212, 2004. (Pubitemid 39575875)
30. Spector SL, Wangaard CH, and Farr RS. Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J Allergy Clin Immunol 64:500-506, 1979. (Pubitemid 10206609)
31. Marseglia GL, Cirillo I, Vizzaccaro A, et al. Role of forced expiratory flow at 25-75% as an early marker of small airways impairment in subjects with allergic rhinitis. Allergy Asthma Proc 28:74-78, 2007.
32. Lamblin C, Brichet A, Perez T, et al. Long-term follow-up of pulmonary function in patients with nasal polyposis. Am J Respir Crit Care Med 161:406-413, 2000. (Pubitemid 30129445)
33. Szczeklik A, Nizankowska E, and Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 16:432-436, 2000.
34. Hope AP, Woessner KA, Simon RA, et al. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 123:406-410, 2009.
35. Milewski M, Mastalerz L, Nizankowska E, et al. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 101:581-586, 1998.
36. Alonso-Llamazares A, Martinez-Cocera C, Dominguez-Ortega J, et al. Nasal provocation test (NPT) with aspirin: A sensitive and safe method to diagnose aspirin-induced asthma (AIA). Allergy 57:632-635, 2002. (Pubitemid 34680797)